Kendra Wong
Comptroller/Controller/Auditor en LENSAR, INC. .
Fortuna: 123 892 $ al 30/04/2024
Cargos activos de Kendra Wong
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LENSAR, INC. | Comptroller/Controller/Auditor | 11/01/2022 | - |
| Corporate Officer/Principal | 01/03/2021 | 11/01/2022 |
Historial de carrera de Kendra Wong
Antiguos cargos conocidos de Kendra Wong.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01/07/2018 | 01/03/2021 |
Formación de Kendra Wong.
| University of California, Davis | Undergraduate Degree |
| Arizona State University | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LENSAR, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Bolsa de valores
- Insiders
- Kendra Wong
- Experiencia
